华润医药(03320.HK)巯嘌呤片(II)获得药品注册证书

阿斯达克财经
11 Feb

华润医药(03320.HK) 宣布,集团旗下华润双鹤药业收到国家药品监督管理局颁发的巯嘌呤片(II)《药品注册证书》,并获批上市。

该药物适用于儿童急性淋巴细胞白血病(ALL)及急性非淋巴细胞白血病,慢性粒细胞白血病的急变期。(sl/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-11 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10